Skip to content

The expression of Specialized Pro-Resolving Mediators in patients with brain injury

The expression of Specialized Pro-Resolving Mediators in traumatic brain injury and their role in improving neuronal viability and cognitive function recovery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100516
Enrollment
Unknown
Registered
2025-04-10
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Interventions

Observation group:None
control group:None

Sponsors

The Third Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Diagnosed with traumatic brain injury (TBI) and a Glasgow Coma Scale (GCS) score of less than 15 upon admission; 3.Underwent neurosurgical intervention for TBI and received postoperative cerebrospinal fluid (CSF) drainage; 4.Enrollment within one week (7 days) after surgery; 5.Informed consent has been obtained from the patient or their legal representative for participation in the study. Control group: 1. Age>= 18 years old; 2. patients with non-traumatic head trauma undergoing subarachnoid anesthesia;3.With the consent of the affected party to participate in this experiment.

Exclusion criteria

Exclusion criteria: 1.Pregnant women, individuals under 18 years of age, or patients with end-stage diseases; 2.Patients with severe injuries in other body regions (Injury Severity Score [ISS] >= 3); 3.Patients with other neurological disorders (e.g., Alzheimer’s disease, multiple sclerosis); 4.Patients who have active infections, are recovering from recent infections, or have chronic inflammatory conditions; 5.Patients with immunodeficiency or autoimmune diseases; 6.Patients who underwent emergency surgery; 7.Patients or their legal representatives who decline to participate in the study.

Design outcomes

Primary

MeasureTime frame
Specialized Pro-Resolving Mediators Series;Glasgow Outcome Scale assessed at 3 months post-injury;Length of hospital stay;Inflammatory indicators;

Secondary

MeasureTime frame
Length of ICU stay;Duration of mechanical ventilation;

Countries

China

Contacts

Public ContactJie Chen

The Third Affiliated Hospital of Wenzhou Medical University

woshichenjie@126.com+86 135 8740 9966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026